Alisa Secaida was diagnosed with advanced lung cancer at age 35. The wife and mother of two had never smoked. The diagnosis was a shock but her journey took a positive turn when doctors at City of Hope, led by Ravi Salgia, M.D., Ph.D., discovered a rare genetic marker, ALK-positive, making her tumor treatable with targeted therapies. Alisa's relentless spirit, combined with innovative treatments like Keytruda, chemotherapy, and tyrosine kinase inhibitors, have been instrumental in controlling her cancer. Her story underscores the vital role of genetic testing and advanced therapies and research in cancer treatment. “If I had gone to some run-of-the-mill oncologist, I probably wouldn’t be here now,” she said. “I wholeheartedly believe that City of Hope and Dr. Salgia have my best interests at heart. Their goal is to give their patients as much time with their loved ones as possible. I owe them a great debt.” Read more about Alisa's story at the link in our bio. #WorldLungCancerDay